Herbas VPB

Print
EN | LT
Supplementary protection
LT - Anti-il-5 antikūnų skyrimo būdai
EN - METHODS FOR ADMINISTERING ANTI-IL-5 ANTIBODIES
SPC
(11) Number of the document C 2152290
(68) Number of the document 2152290
(21) Application number for Supplementary Protection Certificate PA 2016 005
(22) Date of filing the application 2016-03-03
(41) Date of publication of the application 2016-03-25
Date of publication of SPC 2017-06-12
(24) Date of coming into effect of SPC 2028-05-01
Applicant
(71) GlaxoSmithKline LLC, Corporation Service Company 2711 Centreville Road Suite 400, Wilmington, Delaware 19808, US
Grantee
(73) GlaxoSmithKline LLC, Corporation Service Company 2711 Centreville Road Suite 400, Wilmington, Delaware 19808, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/15/1043/001-002, 2015-12-02
Calculated date of expiry of the SPC
(94) 2030-12-07
Name of the product protected by the basic patent
(95) Mepolizumabas
Paediatric extension
Request filed SPC extension granted until Request refused
2018-10-25 2031-06-07
Legal status
SPC term extension granted
Last update date 2021-10-22